Cite
HARVARD Citation
Riedl, J. et al. (2020). The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine: post hoc analysis of an Austrian multicenter, noninterventional study. Therapeutic advances in medical oncology. p. . [Online].